Experience

MEDICAL SCIENCE CONSULTING (MSC)

• Spain
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Medical Writer

  • May 2018 - Present



Inspiralia

• Spain
• Fundraising
• 1 - 100 Employee

• Freelance Proposal Writer

  • Apr 2018 - Oct 2018



New Jersey Institute of Technology

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Associate

  • Aug 2015 - Sep 2017

  Every year more than 12000 new cases of spinal cord injuries are diagnosed in the US. Although there is no actual cure, in some cases there is a recovery in locomotion. However little is still known about how the recovery process works. By using the simple neuronal system of the nematode C. elegans we are studying how locomotion is affected by neuronal damage and subsequent regeneration. Every year more than 12000 new cases of spinal cord injuries are diagnosed in the US. Although there is no actual cure, in some cases there is a recovery in locomotion. However little is still known about how the recovery process works. By using the simple neuronal system of the nematode C. elegans we are studying how locomotion is affected by neuronal damage and subsequent regeneration.



The City College of New York

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Researcher

  • Oct 2011 - Jul 2015

  Using the nematode C. elegans we studied the molecular basis of Alzheimer's disease (AD). The presence of amyloid plaques, whose major component is a cleavage product of the amyloid precursor protein (APP), is one of the neuropathological features found in patients with Alzheimer’s disease. However, the physiological function of APP remains unclear. To gain insights into the role of APP, we are studying apl-1, the APP ortholog in C. elegans. apl-1 is essential for viability and its activity affects multiple metabolic processes by interacting with the insulin IIS/daf-2 and heterochronic pathways. My main project focused on finding proteins that can be affecting apl-1 functionality. We found that the receptor protein tyrosine phosphatase MOA-1 (modifier of apl-1) may be important regulating apl-1 function. Using different techniques (such as genetic screenings, generation of transgenic lines by microinjection, RNAi, qPCRs, behavioural assays...) we have found that moa-1 and apl-1 interact genetically affecting the insulin and heterochronic pathways.

• Lecturer

  • Aug 2014 - Jun 2015

  Teaching Fundamentals of Biology course to College students



Bellvitge Biomedical Research Institute - IDIBELL

• Spain
• Research Services
• 300 - 400 Employee

• Postdoc Researcher

  • Feb 2011 - Jul 2011

  Study of the cohesin protein complex and the diseases associated with them, specifically Cornelia de Lange syndrome. We worked both with patient derived cell lines and Saccharomyces cerevisiae. Also, performed whole exome sequencing. Study of the cohesin protein complex and the diseases associated with them, specifically Cornelia de Lange syndrome. We worked both with patient derived cell lines and Saccharomyces cerevisiae. Also, performed whole exome sequencing.



Universitat Pompeu Fabra

• Spain
• Higher Education
• 700 & Above Employee

• PhD student

  • Jan 2005 - Jul 2010

  Study of the transcription factor HHex, essential for liver development by using cell lines and mouse embryos.Defended my PhD titled: " Characterization of novel Hhex partners: SOX13 and c-Myc. New mechanism for the regulation of Wnt/TCF and c-Myc pathways". Study of the transcription factor HHex, essential for liver development by using cell lines and mouse embryos.Defended my PhD titled: " Characterization of novel Hhex partners: SOX13 and c-Myc. New mechanism for the regulation of Wnt/TCF and c-Myc pathways".